Patients should stop the medication and contact their healthcare provider immediately if they experience: Severe or persistent abdominal pain (especially if radiating to the back), which could indicate pancreatitis Persistent vomiting preventing adequate fluid intake Signs of dehydration (dark urine, dizziness, reduced urination) Yellowing of skin or eyes (jaundice) or pale stools Unexplained fever Severe diarrhoea lasting more than 48 hours Treatment continuation is reviewed regularly, with decisions based on efficacy, tolerability, and ongoing clinical need
EGR-1 and NAB2 are transcription factors involved in regulating cell growth, migration, and angiogenesis, indicating a broader influence on gene expression critical for tissue repair
Even small variations in manufacturing can affect how the molecule behaves
Delayed Pro: Designed to bypass the upper digestive tract and release in the lower intestines
Appetite suppression becomes more consistent and less dramatic
Do not take semaglutide if you are pregnant, planning to become pregnant, or breastfeeding